An AI tool analyzing CCTA images can predict future cardiovascular events and death in patients with suspected stable coronary artery disease.
Key Details
- 1The FISH&CHIPS study involved 7,836 patients who underwent AI-derived FFR-CT analysis from an initial 90,553 receiving CCTA.
- 2Lower FFR-CT values correlated with significantly increased rates of MI, cardiovascular death, and all-cause mortality independent of traditional risk factors.
- 3Patients with severely reduced FFR-CT had a four-fold risk of heart attack and triple risk of death versus those with normal values.
- 4The FFR-CT AI analysis (by HeartFlow) provided additive prognostic value over classical cardiovascular risk scores.
- 5This is the first large-scale evidence of FFR-CT's independent prognostic power in stable CAD.
- 6Study funded by UK MRC; HeartFlow provided analysis but did not fund or direct the study.
Why It Matters
This research demonstrates real-world prognostic utility for AI-based imaging tools in cardiovascular risk prediction, supporting expanded adoption of AI-enhanced CT in personalized patient management and reducing unnecessary procedures.
Source
EurekAlert
Related News
•EurekAlert
AI Accelerates Radiopharmaceuticals, Boosts Personalized Dosimetry in Cancer
Machine learning is driving advancements in radiopharmaceutical drug discovery and optimizing patient-specific dosimetry for precision cancer therapy.
•EurekAlert
Physicians Overly Trust Erroneous AI, Ignore Contradictory Evidence
Physicians tend to trust incorrect AI advice, even when evidence contradicts it, suggesting risks in clinical decision-making with AI tools.
•EurekAlert
Concerns Raised Over Unverified Datasets in AI Health Prediction Models
A new study finds widely used AI health prediction models are built on datasets with unverifiable origins, raising safety and validity concerns.